Suppr超能文献

运动障碍学会标准:在多系统萎缩中的临床应用。

The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System Atrophy.

机构信息

Department of Neurology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Japan.

Department of Neurology, Obihiro Kosei General Hospital, Japan.

出版信息

Intern Med. 2024 Nov 1;63(21):2903-2912. doi: 10.2169/internalmedicine.3275-23. Epub 2024 Mar 18.

Abstract

Objective In 2022, Wenning et al. proposed the Movement Disorder Society Criteria (MDS criteria) for the Diagnosis of Multiple System Atrophy (MSA). These criteria were expected to provide useful alternatives to the second consensus statement. We examined trends in these diagnostic criteria. Methods We used patient data registered with the Hokkaido Rare Disease Consortium for Multiple System Atrophy, which has been recruiting patients with MSA through medical facilities in Hokkaido since November 2014. Patients were evaluated according to the MDS criteria based on neurological examinations and imaging findings at three separate times: the first evaluation, the time of enrollment (diagnosis), and the most recent evaluation (final evaluation). Results The MDS criteria were examined in 68 of 244 patients enrolled between November 2014 and July 2022. At the initial evaluation, the classifications were as follows: clinically established (n=27; 39.7%); clinically probable (n=13; 19.1%); possible prodromal (n=12; 17.6%); and negative [did not meet criteria (n=16; 23.5%)]. At the time of diagnosis, the classifications were as follows: clinically established (n=45; 66.2%); clinically probable (n=12; 17.6%); possible prodromal (n=4; 5.9%); and negative (n=7; 10.3%). At the final evaluation, the classifications were as follows: clinically established (n=52; 76.5%); clinically probable (n=9; 13.2%); possible prodromal (n=2; 2.9%); and negative (n=5; 7.4%). Conclusion We were able to clarify the changes in the criteria values and transition of patients due to the clarification of imaging and supportive findings in the MDS criteria.

摘要

目的 2022 年,Wenning 等人提出了多系统萎缩(MSA)的运动障碍学会标准(MDS 标准)。这些标准有望为第二份共识声明提供有用的替代方案。我们研究了这些诊断标准的趋势。

方法 我们使用了北海道多系统萎缩罕见病联合会登记的患者数据,该联合会自 2014 年 11 月以来一直在北海道的医疗机构中招募 MSA 患者。患者根据 MDS 标准进行评估,该标准基于三次单独的神经检查和影像学发现:第一次评估、入组时(诊断)和最近一次评估(最终评估)。

结果 在 2014 年 11 月至 2022 年 7 月期间入组的 244 名患者中,有 68 名患者接受了 MDS 标准的检查。在初始评估时,分类如下:临床确诊(n=27;39.7%);临床可能(n=13;19.1%);可能前驱期(n=12;17.6%);和阴性[不符合标准(n=16;23.5%)]。在诊断时,分类如下:临床确诊(n=45;66.2%);临床可能(n=12;17.6%);可能前驱期(n=4;5.9%);和阴性(n=7;10.3%)。在最终评估时,分类如下:临床确诊(n=52;76.5%);临床可能(n=9;13.2%);可能前驱期(n=2;2.9%);和阴性(n=5;7.4%)。

结论 我们能够通过 MDS 标准中影像学和支持性发现的澄清,阐明标准值的变化和患者的转变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a678/11604380/d69bf20e4ff4/1349-7235-63-2903-g001.jpg

相似文献

1
The Movement Disorder Society Criteria: Its Clinical Usefulness in Multiple System Atrophy.
Intern Med. 2024 Nov 1;63(21):2903-2912. doi: 10.2169/internalmedicine.3275-23. Epub 2024 Mar 18.
2
Comparison of the second consensus statement with the movement disorder society criteria for multiple system atrophy: A single-center analysis.
Parkinsonism Relat Disord. 2023 Jan;106:105242. doi: 10.1016/j.parkreldis.2022.105242. Epub 2022 Dec 14.
3
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
5
Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.
Neurology. 2023 Dec 12;101(24):e2460-e2471. doi: 10.1212/WNL.0000000000207905. Epub 2023 Oct 10.
6
Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy.
Mov Disord. 2023 Mar;38(3):444-452. doi: 10.1002/mds.29304. Epub 2023 Jan 6.
7
[New MDS Criteria for the Diagnosis of Multiple System Atrophy: Overview and Genetic Viewpoint].
Brain Nerve. 2023 Feb;75(2):117-121. doi: 10.11477/mf.1416202291.
8
A Review on the Clinical Diagnosis of Multiple System Atrophy.
Cerebellum. 2023 Oct;22(5):825-839. doi: 10.1007/s12311-022-01453-w. Epub 2022 Aug 19.

本文引用的文献

1
Validation Study of the MDS Criteria for the Diagnosis of Multiple System Atrophy in the Mayo Clinic Brain Bank.
Neurology. 2023 Dec 12;101(24):e2460-e2471. doi: 10.1212/WNL.0000000000207905. Epub 2023 Oct 10.
2
Pathological Validation of the MDS Criteria for the Diagnosis of Multiple System Atrophy.
Mov Disord. 2023 Mar;38(3):444-452. doi: 10.1002/mds.29304. Epub 2023 Jan 6.
3
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy.
Mov Disord. 2022 Jun;37(6):1131-1148. doi: 10.1002/mds.29005. Epub 2022 Apr 21.
5
Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.
Brain. 2019 Sep 1;142(9):2813-2827. doi: 10.1093/brain/awz189.
6
A critique of the second consensus criteria for multiple system atrophy.
Mov Disord. 2019 Jul;34(7):975-984. doi: 10.1002/mds.27701. Epub 2019 Apr 29.
7
When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.
Neurology. 2015 Aug 4;85(5):404-12. doi: 10.1212/WNL.0000000000001807. Epub 2015 Jul 2.
8
Multiple-system atrophy.
N Engl J Med. 2015 Jan 15;372(3):249-63. doi: 10.1056/NEJMra1311488.
9
Mutations in COQ2 in familial and sporadic multiple-system atrophy.
N Engl J Med. 2013 Jul 18;369(3):233-44. doi: 10.1056/NEJMoa1212115. Epub 2013 Jun 12.
10
Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy.
PLoS One. 2013 Apr 23;8(4):e62354. doi: 10.1371/journal.pone.0062354. Print 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验